Arrhythmogenic right ventricular cardiomyopathy: What is needed for a cure?

Herz

Volumn 37, Issue 6, 2012, Pages 657-663

  Thiene, G ^a   Rigato, I ^a   Pilichou, K ^a   Corrado, D ^a   Basso, C ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Arrhythmogenic right ventricular cardiomyopathy; Pathogenesis; Sudden death; Therapy

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; SOTALOL; VERAPAMIL;

ARRHYTHMOGENESIS; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CARDIOMYOPLASTY; CARDIOVASCULAR GENE THERAPY; CONGESTIVE HEART FAILURE; DRUG EFFICACY; HEART ARREST; HEART DEATH; HEART RIGHT VENTRICLE DYSPLASIA; HEART TRANSPLANTATION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; NONHUMAN; PRIMARY PREVENTION; RISK REDUCTION;

ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; BODY SURFACE POTENTIAL MAPPING; DEFIBRILLATORS, IMPLANTABLE; EARLY DIAGNOSIS; HUMANS; MAGNETIC RESONANCE IMAGING, CINE;

EID: 84867817089     PISSN: 03409937     EISSN: 16156692     Source Type: Journal    
DOI: 10.1007/s00059-012-3678-x     Document Type: Article

References (42)

1. Thiene G, Corrado D, Basso C (2007) Arrhythmogenic right ventricular cardiomyopathy/dysplasia. Orphanet J Rare Dis 2:45
2. Basso C, Corrado D, Marcus FI, et al. (2009) Arrhythmogenic right ventricular cardiomyopathy. Lancet 373:1289-1300
3. Basso C, Bauce B, Corrado D, Thiene G (2011) Pathophysiology of arrhythmogenic cardiomyopathy. Nat Rev Cardiol 9:223-233
4. Marcus FI, McKenna WJ, Sherrill D, et al. (2010) Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation 121:1533-1541
5. Bauce B, Basso C, Rampazzo A, et al. (2005) Clinical profile of four families with arrhythmogenic right ventricular cardiomyopathy caused by dominant desmoplakin mutations. Eur Heart J 26:1666-1675
6. Sen-Chowdhry S, Syrris P, Prasad SK, et al. (2008) Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity. J Am Coll Cardiol 52:2175-2187
7. Sen-Chowdhry S, Syrris P, Ward D, et al. (2007) Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia/cardiomyopathy provides novel insights into patterns of disease expression. Circulation 115:1710-1720
8. Basso C, Corrado D, Thiene G (2010) Arrhythmogenic right ventricular cardiomyopathy: what's in a name? From a congenital defect (dysplasia) to a genetically determined cardiomyopathy (dystrophy). Am J Cardiol 106:275-277
9. Corrado D, Basso C, Thiene G (2011) Arrhythmogenic cardiomyopathy. Cardiac Electrophysiology Clinics, Elsevier, New York
10. Perazzolo Marra M, Leoni L, Bauce B, et al. (2012) Imaging study of ventricular scar in arrhythmogenic right ventricular cardiomyopathy: comparison of 3D standard electroanatomical voltage mapping and contrast-enhanced cardiac magnetic resonance. Circ Arrhythm Electrophysiol 5:91-100
11. Corrado D, Basso C, Leoni L, et al. (2005) Three-dimensional electroanatomic voltage mapping increases accuracy of diagnosing arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation 111:3042-3050
12. Garcia FC, Bazan V, Zado ES, et al. (2009) Epicardial substrate and outcome with epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation 120:366-375
13. Corrado D, Basso C, Leoni L, et al. (2008) Three-dimensional electroanatomical voltage mapping and histologic evaluation of myocardial substrate in right ventricular outflow tract tachycardia. J Am Coll Cardiol 51:731-739
14. Vasaiwala SC, Finn C, Delpriore J, et al. (2009) Prospective study of cardiac sarcoid mimicking arrhythmogenic right ventricular dysplasia. J Cardiovasc Electrophysiol 20:473-476
15. Corrado D, Leoni L, Link MS, et al. (2003) Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation 108:3084-3091
16. Corrado D, Calkins H, Link M, et al. (2010) Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia. Circulation 122:1144-1152
17. Thiene G, Nava A, Corrado D, et al. (1988) Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med 318:129-133
18. Corrado D, Basso C, Rizzoli G, et al. (2003) Does sports activity enhance the risk of sudden death in adolescents and young adults? J Am Coll Cardiol 42:1959-1963
19. Corrado D, Basso C, Pavei A, et al. (2006) Trends in sudden cardiovascular death in young competitive athletes after implementation of a pre-participation screening program. JAMA 296:1593-1601
20. Bauce B, Nava A, Beffagna G, et al. (2010) Multiple mutations in desmosomal proteins encoding genes in arrhythmogenic right ventricular cardiomyopathy/dysplasia. Heart Rhythm 7:22-29
21. Xu T, Yang Z, Vatta M, et al. (2010) Multidisciplinary Study of Right Ventricular Dysplasia Investigators. Compound and digenic heterozygosity contributes to arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol 55:587-597
22. Asimaki A, Tandri H, Huang H, et al. (2009) A new diagnostic test for arrhythmogenic right ventricular cardiomyopathy. N Engl J Med 360:1075-1084
23. Kaplan SR, Gard JJ, Protonotarios N, et al. (2004) Remodeling of myocyte gap junctions in arrhythmogenic right ventricular cardiomyopathy due to a deletion in plakoglobin (Naxos disease). Heart Rhythm 1:3-11
24. Kaplan SR, Gard JJ, Carvajal-Huerta L, et al. (2004) Structural and molecular pathology of the heart in Carvajal syndrome. Cardiovasc Pathol 13:26-32
25. Rizzo S, Lodder EM, Verkerk AO, et al. (2012) Intercalated disc abnormalities, reduced na+ current density and conduction slowing in desmoglein-2 mutant mice prior to cardiomyopathic changes. Cardiovasc Res 95-409-418
26. Garcia-Gras E, Lombardi R, Giocondo MJ, et al. (2006) Suppression of canonical Wnt/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy. J Clin Invest 116:2012-2021
27. Basso C, Thiene G, Corrado D, et al. (1996) Arrhythmogenic right ventricular cardiomyopathy: dysplasia, dystrophy or myocarditis? Circulation 94:983-991
28. Pilichou K, Remme CA, Basso C, et al. (2009) Myocyte necrosis underlies progressive myocardial dystrophy in mouse dsg2-related arrhythmogenic right ventricular cardiomyopathy. J Exp Med 206:1787-1802
29. Migliore F, Zorzi A, Michieli P, et al. (2012) Prevalence of cardiomyopathy in Italian asymptomatic children with electrocardiographic T-wave inversion at preparticipation screening. Circulation 125:529-538
30. Corrado D, Basso C, Thiene G (2012) Sudden cardiac death in athletes: what is the role of screening? Curr Opin Cardiol 27:41-48
31. Thiene G, Carturan E, Corrado D, Basso C (2010) Prevention of sudden cardiac death in the young and in athletes: dream or reality? Cardiovasc Pathol 19:207-217
32. Wichter T, Paul M, Eckardt L, et al. (2005) Arrhythmogenic right ventricular cardiomyopathy. Antiarrhythmic drugs, catheter ablation, or ICD? Herz 30:91-101
33. Dalal D, Jain R, Tandri H, et al. (2007) Long-term efficacy of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol 50:432-440
34. Thiene G, Angelini A, Basso C, et al. (1998) Novel heart diseases requiring transplantation. Adv Clin Path 2:65-73
35. Wlodarska EK, Wozniak O, Konka M, et al. (2006) Thromboembolic complications in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. Europace 8:596-600
36. Chachques JC, Argyriadis PG, Fontaine G, et al. (2003) Right ventricular cardiomyoplasty: 10-year follow-up. Ann Thorac Surg 75:1464-1468
37. Kirchhof P, Fabritz L, Zwiener M, et al. (2006) Age- and training-dependent development of arrhythmogenic right ventricular cardiomyopathy in heterozygous plakoglobin-deficient mice. Circulation 114:1799-1806
38. Fabritz L, Hoogendijk MG, Scicluna BP, et al. (2011) Load-reducing therapy prevents development of arrhythmogenic right ventricular cardiomyopathy in plakoglobin-deficient mice. J Am Coll Cardiol 57:740-750
39. Charron P, Arad M, Arbustini E, et al. (2010) Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 31:2715-2726
40. Charron P, Héron D, Gargiulo M, et al. (2004) Prenatal molecular diagnosis in hypertrophic cardiomyopathy: report of the first case. Prenat Diagn 24:701-703
41. Kuliev A, Pomerantseva E, Polling D, et al. (2012) PGD for inherited cardiac diseases. Reprod Biomed Online 24:443-453
42. Bushby K, Lochmüller H, Lynn S, Straub V (2009) Interventions for muscular dystrophy: molecular medicines entering the clinic. Lancet 374:1849-1856